300639 凯普生物
2026/03 - 三个月
(K)
2025/12
(K)
2024/12
(K)
2023/12
(K)
2022/12
(K)
经营活动产生之现金流量净额24,951341,60978,778319,5981,309,216
投资活动产生之现金流量净额(319,850)(143,247)(110,350)(285,214)(604,747)
筹资活动产生之现金流量净额(12,271)(143,116)(75,269)(294,400)(219,409)
汇率变动对现金及现金等价物的影响(11,942)(9,395)7,58894813,403
现金及现金等价物净增加/(减少)(319,112)45,851(99,252)(259,068)498,463
期初现金及现金等价物余额707,989662,116761,3681,020,436521,973
期末现金及现金等价物余额388,877707,967662,116761,3681,020,436